Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03830567 · ClinicalTrials.gov registry record
Pharmacists Expand Access to Reproductive heaLthcare
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 471
- Enrollment target
NCT03830567 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 471 participants.
The verdict
NCT03830567 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 471 participants
- Enrollment target
Study Summary
Prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates, as well as measures of safety and acceptability.
Interventions
- OTHER Pharmacist prescription
- OTHER Clinician prescription
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 471 participants |
| Start Date | 2019-01-27 |
| Est. Completion | 2022-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03830567
The ClinicalTrials.gov registry entry for NCT03830567 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 471 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pharmacist prescription is the first listed.
NCT03830567 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03830567 about?
NCT03830567 is a clinical study titled "Pharmacists Expand Access to Reproductive heaLthcare". Prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates, as well as measures of safety and acceptability.
What is the current status of trial NCT03830567?
This trial is currently completed. The enrollment target is 471 participants. The study started on 2019-01-27. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT03830567?
The interventions under investigation include: Pharmacist prescription (OTHER), Clinician prescription (OTHER).
Who is sponsoring clinical trial NCT03830567?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.